Acadia Pharmaceuticals (ACAD) Asset Utilization Ratio (2011 - 2026)

Acadia Pharmaceuticals' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.69 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 19.53% year-over-year to 0.69 in Q1 2026; TTM through Mar 2026 was 0.69, a 19.53% decrease from a year earlier, with the FY2025 full-year figure at 0.78, down 21.27% from the prior year.
• Asset Utilization Ratio slipped to 0.69 in Q1 2026 per ACAD's latest filing, from 0.74 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.05 in Q4 2023 and bottomed at 0.69 in Q1 2026.
• The 5-year median for Asset Utilization Ratio is 0.86 (2025), against an average of 0.88.
• Across the five-year window, Asset Utilization Ratio surged 32.27% in 2022 and fell 19.53% in 2026, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.87 in 2022, then grew by 21.01% to 1.05 in 2023, then retreated by 15.85% to 0.88 in 2024, then slipped by 16.35% to 0.74 in 2025, then retreated by 6.64% to 0.69 in 2026.
• Per Business Quant, the three latest ACAD Asset Utilization Ratio figures stand at 0.69 (Q1 2026), 0.74 (Q4 2025), and 0.82 (Q3 2025).